Wakefit, Corona Remedies' GMPs jump up to 18% ahead of IPOs

Mansi Agarwal, Published on Dec 3rd, 2025

Wakefit, Corona Remedies' GMPs jump up to 18% ahead of IPOs

Unlisted shares of Wakefit and Corona Remedies were trading at a premium of up to 18% in the grey market on Wednesday, ahead of their IPOs next week. Home and furnishings startup Wakefit has set a price band of ₹185-195 per share for its ₹1,289 crore IPO. Pharma firm Corona Remedies' IPO is worth ₹655.37 crore.

Read Full Article ...

© yugma 2025

Google Play and the Google Play logo are trademarks of Google LLC.

Apple and the Apple logo are trademarks of Apple Inc.